This topic contains a solution. Click here to go to the answer

Author Question: Prevalence figures for students with disabilities are used to a. make sure that states are not ... (Read 448 times)

xroflmao

  • Hero Member
  • *****
  • Posts: 515
Prevalence figures for students with disabilities are used to
 
  a. make sure that states are not over-identifying a handicapping condition.
  b. monitor the effectiveness of special education programs for specific groups of students.
  c. determine funding allocations for these students.
  d. provide social service agencies with information about where increased testing should be done.

Question 2

In the 2008-2009 school year, what percentage of pre-kindergarten through secondary students qualify for special education services?
 
  a. 2.5 percent
  b. 7 percent
  c. 13,2 percent
  d. 25 percent



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

InfiniteSteez

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

c

Answer to Question 2

c





 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library